FUJIFILM SHOWCASES ARTIFICIAL INTELLIGENCE INITIATIVE AND ADVANCES AI EDUCATION AT RSNA 2018

  

STAMFORD, Conn., November 15, 2018 (Booth #2545) FUJIFILM Medical Systems U.S.A., Inc. will present, REiLI,* the company’s global Medical Imaging and Informatics Artificial Intelligence (AI) technology initiative at the Radiological Society of North America’s (RSNA) annual meeting to be held from November 25-30, 2018 at McCormick Place in Chicago, IL. In addition, on Monday evening, November 26th, Fujifilm will host an educational symposium focused on the impact AI has on enterprise imaging now and into the future. 

 

 “Fujifilm has long been recognized as an innovator and together with key partners we are pushing the boundaries of AI technology to support radiologists and the healthcare enterprise,” said Johann Fernando, Ph.D., Chief Operating Officer of FUJIFILM Medical Systems U.S.A., Inc. “At RSNA, we are excited to showcase our impressive progress in AI as well as accelerate AI education for healthcare providers.” 

 

Under the REiLI brand, Fujifilm is developing AI technologies that strongly support diagnostic imaging workflow, leveraging the combination of deep learning in its AI technology with Fujifilm’s image processing heritage. Applications currently in development include but are not limited to: Region Recognition, an AI technology to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions; Computer Aided Detection, an AI technology to reduce the time of image interpretation and support radiologists’ clinical decision making; Workflow Support, using AI technology to realize optimal study prioritization, alert communications of AI findings, and report population automation. 

 

“The depth and scope of our REiLI brand is growing stronger everyday thanks to insights gained from our strategic Synapse customers as well as collaborations with researchers at prestigious medical institutes,” said Bill Lacy, Vice President of Medical Informatics at FUJIFILM Medical Systems, U.S.A., Inc. “Our goal is to provide an open platform which manages the workflow and delivery of AI technologies through Synapse clinical applications enabled for AI results and use cases, and realize a new and more powerful diagnostic workflow that advances the field of radiology.” 

 

RSNA attendees are encouraged to learn more about REiLI at Booth #2545 and participate in the following Fujifilm-hosted activities:

 

In-Booth Artificial Intelligence Laboratory

At booth #2545, attendees can visit Fujifilm’s in-booth AI Lab. The lab will feature dedicated workstations demonstrating AI platform use cases within Synapse 5 PACS driven by REiLI. This is an exciting opportunity for attendees to witness first-hand the speed and depth of integrated workflows achieved with Fujifilm’s REiLI technology coupled with the Synapse 5 server-side PACS system. 

 

Educational Symposium—“AI Powering Enterprise Imaging”

This educational symposium will explore the impact that AI has on enterprise imaging today and what to expect tomorrow. Featuring a panel discussion by industry thought leaders, attendees will learn about current applications as well as the development of AI algorithms and desired clinical impacts. An interactive session, participants will also have the chance to ask questions and delve into the infrastructure planning required to enable AI throughout the enterprise.

 

This free event will take place on Monday, November 26th from 6:30PM-9:00PM at Marriott Marquis, conveniently located just steps from McCormick Place. Complimentary dinner and refreshments will be served. Space is limited. To register, visit rsna.fujimed.com/ai-symposium. 

 

AI Symposium Panelists 

 

 

 

 

 

 

 

 

 

 

 

 

Fujifilm AI News: 

With the goal to accelerate AI development, Fujifilm entered a joint research agreement with Indiana University School of Medicine in August to develop the application of AI in medical imaging diagnostic support systems. Designed to support physicians by detecting suspicious lesions in images, comparing results with prior studies and implementing semi-automated reporting, this AI application is expected to increase significantly the efficiency of diagnostic medical imaging in patient care. 

 

Fujifilm’s AI Research Project is based in Raleigh, North Carolina—the global development headquarters for Fujifilm’s Synapse Enterprise Imaging portfolio—in collaboration with Fujifilm Corporation’s development team in Tokyo that provides a wide range of image recognition technologies. In an increasingly complex healthcare environment with massive datasets and rising demand for high-quality care, AI technology has the potential to change the practice of medicine.

 

To learn more information, or book your RSNA demo with Fujifilm, visit rsna.fujimed.com.

 

*Fujifilm's artificial intelligence software is a work in progress and is not commercially available in the United States.

 

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy supplies high quality, technologically advanced endoscopic imaging solutions and devices to the medical field. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.   

 

FUJIFILM Holdings Corporation in Tokyo, Japan, brings innovative solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies derived from photographic film. Its proprietary core technologies contribute to the fields of healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.

 

 

Contact:

Danielle Brown

Fujifilm

(914) 574-3273

danielle.brown@fujifilm.com